← The Wire
KNSANasdaq
Kiniksa Pharmaceuticals International, plc
Pharmaceutical Preparations · CIK 1730430
Developing and commercializing novel therapies for diseases with unmet need, focusing on cardiovascular indications
red 8-K · 90d
$3.99B
Market cap
$62.41
Last close
+5.4%
1D
+9.2%
5D
1.5M
Volume
Price · last 39 sessions+8.3%
May 4L $46.92 · H $62.41Jun 29
163
Total filings
May 29, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 29, 20268-KMaterial AgreementMay 26, 2026SC 13D/ASC 13D/AMay 26, 20268-KExecutive ChangeMay 1, 202610-Q10-QApr 28, 20268-KResults of OperationsApr 28, 2026DEFA14ADEFA14AApr 16, 2026DEF 14ADEF 14AApr 16, 202610-K10-KFeb 24, 20268-KResults of OperationsFeb 24, 20268-KExecutive ChangeJan 14, 20268-KResults of OperationsJan 12, 202610-Q10-QOct 28, 20258-KResults of OperationsOct 28, 20258-KReg FD DisclosureSep 3, 202510-Q10-QJul 29, 20258-KResults of OperationsJul 29, 20258-KReg FD DisclosureJun 5, 20258-KShareholder VoteJun 3, 2025DEFA14ADEFA14AMay 28, 2025DEFA14ADEFA14AMay 9, 202510-Q10-QApr 29, 20258-KResults of OperationsApr 29, 20258-KExecutive ChangeApr 23, 2025DEFA14ADEFA14AApr 21, 2025DEF 14ADEF 14AApr 21, 202510-K10-KFeb 25, 20258-KAgreement Terminated · Results of OperationsFeb 25, 20258-KResults of OperationsJan 13, 2025SC 13GSC 13GNov 8, 202410-Q10-QOct 29, 20248-KResults of OperationsOct 29, 2024SC 13GSC 13GOct 21, 20248-KExecutive ChangeOct 7, 202410-Q10-QJul 25, 20248-KResults of OperationsJul 23, 20248-KMaterial AgreementJun 25, 20248-KCompany UpdateJun 14, 20248-KShareholder VoteJun 5, 2024DEFA14ADEFA14AMay 29, 202410-Q10-QApr 25, 2024DEFA14ADEFA14AApr 23, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 20248-KResults of OperationsApr 23, 20248-KReg FD DisclosureApr 2, 2024DEFA14ADEFA14AMar 29, 2024DEFA14ADEFA14AMar 29, 20248-KCompany UpdateMar 29, 202410-K10-KFeb 28, 20248-KResults of OperationsFeb 28, 2024SC 13GSC 13GFeb 12, 2024SC 13GSC 13GJan 25, 20248-KResults of Operations · Reg FD DisclosureJan 4, 202410-Q10-QNov 2, 20238-KResults of OperationsOct 31, 2023SC 13GSC 13GAug 10, 202310-Q10-QAug 1, 20238-KResults of OperationsJul 25, 20238-KShareholder VoteJun 7, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 2, 2023DEF 14ADEF 14AApr 27, 20238-KReg FD DisclosureMar 13, 202310-K10-KMar 2, 20238-KResults of OperationsFeb 28, 2023SC 13GSC 13GFeb 3, 20238-KResults of OperationsJan 9, 202310-Q10-QNov 3, 20228-KResults of OperationsNov 1, 2022SC 13GSC 13GSep 8, 202210-Q10-QAug 4, 20228-KMaterial Agreement · Results of OperationsAug 3, 20228-KShareholder VoteJun 30, 202210-Q10-QMay 5, 20228-KResults of OperationsMay 3, 2022DEFA14ADEFA14AApr 28, 2022DEF 14ADEF 14AApr 28, 202210-K10-KFeb 24, 20228-KMaterial Agreement · Results of OperationsFeb 22, 2022
Insider Activity
In the 90 days to Mar 9, 2026: 4 sold $6.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 18,741 | $46.24 | $867K |
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 17,981 | $45.58 | $820K |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sell | 22,223 | $44.88 | $997K |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sell | 12,063 | $44.20 | $533K |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sell | 5,714 | $45.92 | $262K |
| Feb 12, 2026 | Quart Barry DDirector | Sell | 2,690 | $45.00 | $121K |
| Feb 10, 2026 | Quart Barry DDirector | Sell | 110 | $45.00 | $5K |
| Feb 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 9,114 | $42.85 | $391K |
| Feb 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 8,731 | $43.72 | $382K |
| Feb 4, 2026 | Quart Barry DDirector | Sell | 2,602 | $45.02 | $117K |
| Feb 3, 2026 | Quart Barry DDirector | Sell | 12,528 | $45.27 | $567K |
| Feb 2, 2026 | Quart Barry DDirector | Sell | 830 | $45.00 | $37K |
| Jan 8, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 12,000 | $41.89 | $503K |
| Dec 15, 2025 | Quart Barry DDirector | Sell | 20,129 | $41.51 | $836K |
| Dec 15, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 12,048 | $41.56 | $501K |
| Dec 8, 2025 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 42,841 | $41.49 | $1.8M |
| Nov 26, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 200 | $42.89 | $9K |
| Nov 17, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 11,825 | $41.30 | $488K |
| Nov 17, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 645 | $40.08 | $26K |
| Nov 12, 2025 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 19,900 | $40.94 | $815K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance